Loading clinical trials...
Loading clinical trials...
This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program foc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Joslin Diabetes Center
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT04805502 · Pregnancy, Overweight and Obesity
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT07415720 · Diabete Type 2, Obesity & Overweight, and more
NCT07525791 · Overweight, Obesity
Joslin Diabetes Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions